In conclusions, the present study is a translational research in which we directly translated the results of genetic and molecular studies into a new idea of AF disease mechanism, which further implicates a therapeutic potential of targeting on KCHIP1 to treat human AF in the future. Here, KCNIP1 is linked to atrial fibrillation.